Sentence examples for improving obesity from inspiring English sources

Various functional foods or natural components have been recently developed for preventing or improving obesity as the alternative means of lifestyle improvement or medical treatment for obesity.

We examined differences in perspectives by years since completing medical school for the following topics: causes of obesity, competence in treating obese patients, perspectives on the health professional most qualified to help obese patients lose or maintain weight, and solutions for improving obesity care.

We evaluated physician perspectives on: (1) causes of obesity, (2) competence in treating obese patients, (3) perspectives on the health professional most qualified to help obese patients lose or maintain weight and (4) solutions for improving obesity care.

We evaluated physician perspectives on the following topics: (1) causes of obesity, (2) competence in treating obese patients, (3) perspectives on the health professional most qualified to help obese patients lose or maintain weight and (4) solutions for improving obesity care.

Application of high-affinity, selective CB1 cannabinoid receptor ligands to attenuate endocannabinoid signaling represents a state-of-the-art approach for improving obesity pharmacotherapy.

Table 4 shows PCP perspectives on solutions for improving obesity care related to physician training and practice-based changes.

Although it is unknown if these lipid compounds would be useful for understanding the pharmacological manipulation of rimonabant on improving obesity-related metabolic abnormalities under current experimental conditions, it may point to an important role of individual lipid molecular species in rimonabant's influence on the management of obesity.

Thus, it is logical to target WAT for improving obesity-related metabolic syndromes, particularly insulin resistance and type 2 diabetes.

Therapeutic approaches targeting adipose tissue have been proven to be effective in improving obesity-related metabolic disorders, and promising new therapies could be developed in the near future.

Likewise, the use of insulin sensitizers and/or AMP-activated protein kinase (AMPK -agonists [ 11] hAMPK -agonistsficial in improving obesity-related metabolic complications in skeletal muscle.

The release of the results from a recently completed National Institutes of Health-funded large clinical trial will provide more information regarding the therapeutic implication of salsalate in improving obesity-related insulin resistance and type 2 diabetes.